Skip to content
OpenCapital
Get started

CVS Health CVS Investments

Investments at other companies

UnitedHealth Group logo
UnitedHealth GroupUNH
$56.79B+9.5%
Cigna logo
CignaCI
$18.9B+23.1%
Centene logo
CenteneCNC
——

Other financials

Income statement

See full
Revenue$100.43B+6.2%
Gross profit$45.0B+3.3%
Operating income$4.7B+38.7%
Net income$2.9B+65.4%
EPS (diluted)$2.30+63.1%

Balance sheet

See full
Cash & equivalents$9.8B-5.6%
Total debt$15.2B-14.2%
Total equity$77.5B+0.7%
Total assets$252.97B-1.0%

Cash flow

See full
Operating cash flow$4.2B-6.7%
CapEx$849.0M+14.3%
Free cash flow$3.4B-10.8%

Valuation

See full
Market cap$139.51B+83.8%
Enterprise value$144.97B+74.4%
P/E47.6×+30.8×
P/S0.3×+0.1×

Profitability

See full
Gross margin44.7%-0.1pp
Operating margin1.5%-1.1pp
Net margin0.7%-0.7pp
FCF margin1.8%—

Returns & leverage

See full
Return on equity3.8%-3.2pp
Debt / equity0.2×0.0×
Current ratio0.9×0.0×

Where this comes from

Reported directly by CVS Health in its filing.

Tagged under the XBRL concept us-gaap:LongTermInvestments.

The official record: CVS Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about CVS Health's investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CVS Health's investments?
CVS Health (CVS) reported investments of $32.41B in Q1 2026.
How has CVS Health's investments changed year-over-year?
CVS Health's investments increased by 12.1% year-over-year, from $28.91B to $32.41B.
What is the long-term trend for CVS Health's investments?
Over 5 years (2020 to 2025), CVS Health's investments has grown at a 9.4% compound annual growth rate (CAGR), from $20.81B to $32.67B.
What does investments mean?
These are investments in securities, joint ventures, or other long-term financial assets that the company intends to hold for more than one year. Unlike current assets, these are not intended for immediate operational liquidity but rather for strategic growth or long-term yield generation. This reflects the company's broader capital allocation strategy.